Harvard Bioscience
HBIO
HBIO
81 hedge funds and large institutions have $111M invested in Harvard Bioscience in 2020 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 30 increasing their positions, 27 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
81
Holders Change
-4
Holders Change %
-4.71%
% of All Funds
1.44%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.02%
New
5
Increased
30
Reduced
27
Closed
9
Calls
$4K
Puts
–
Net Calls
+$4K
Net Calls Change
+$4K
Top Buyers
| 1 |
PCM
1
Portolan Capital Management
Boston,
Massachusetts
|
$5.75M |
| 2 |
HP
2
Harvey Partners
Tarrytown,
New York
|
$4.26M |
| 3 |
3
State Street
Boston,
Massachusetts
|
$2.73M |
| 4 |
4
BlackRock
New York
|
$12.7M |
| 5 |
5
JPMorgan Chase & Co
New York
|
$498K |
